Review



antibodies against mpc1  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Novus Biologicals antibodies against mpc1
    Antibodies Against Mpc1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against mpc1/product/Novus Biologicals
    Average 93 stars, based on 10 article reviews
    antibodies against mpc1 - by Bioz Stars, 2026-02
    93/100 stars

    Images



    Similar Products

    93
    Novus Biologicals antibodies against mpc1
    Antibodies Against Mpc1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against mpc1/product/Novus Biologicals
    Average 93 stars, based on 1 article reviews
    antibodies against mpc1 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc primary antibodies against mpc1
    Primary Antibodies Against Mpc1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against mpc1/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    primary antibodies against mpc1 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Millipore mouse primary antibodies against mpc1
    (A - C) Incorporation of [2- 14 C] pyruvate into total lipids ( A ), or the fatty acyl or glycerol-glyceride fraction of lipids ( B – C ) following treatment of differentiated 3T3L1 adipocytes with 5µM UK5099 (A – B) or siRNA against <t>MPC1</t> or scramble control (C) . (D - E) Total triglyceride accumulation in adipocytes treated with 5µM UK5099 either throughout (D) , or at various time points during (E) , differentiation. (F) Incorporation of [U- 14 C] acetate into total lipids in differentiated 3T3L1 adipocytes treated with or without 5µM UK5099. Data are mean ± SE for at least three experimental replicates (different cell passages). *P<0.05 vs control, ^P<0.05 vs 10% FBS condition in (A) by paired t-test ( B - D and F ), one-way ANOVA ( E ) or 2-way ANOVA ( A ).
    Mouse Primary Antibodies Against Mpc1, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse primary antibodies against mpc1/product/Millipore
    Average 90 stars, based on 1 article reviews
    mouse primary antibodies against mpc1 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    94
    Proteintech antibodies against mpc1
    (A - C) Incorporation of [2- 14 C] pyruvate into total lipids ( A ), or the fatty acyl or glycerol-glyceride fraction of lipids ( B – C ) following treatment of differentiated 3T3L1 adipocytes with 5µM UK5099 (A – B) or siRNA against <t>MPC1</t> or scramble control (C) . (D - E) Total triglyceride accumulation in adipocytes treated with 5µM UK5099 either throughout (D) , or at various time points during (E) , differentiation. (F) Incorporation of [U- 14 C] acetate into total lipids in differentiated 3T3L1 adipocytes treated with or without 5µM UK5099. Data are mean ± SE for at least three experimental replicates (different cell passages). *P<0.05 vs control, ^P<0.05 vs 10% FBS condition in (A) by paired t-test ( B - D and F ), one-way ANOVA ( E ) or 2-way ANOVA ( A ).
    Antibodies Against Mpc1, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against mpc1/product/Proteintech
    Average 94 stars, based on 1 article reviews
    antibodies against mpc1 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    90
    Agrisera antibodies against mpc1 and mpc3
    (A - C) Incorporation of [2- 14 C] pyruvate into total lipids ( A ), or the fatty acyl or glycerol-glyceride fraction of lipids ( B – C ) following treatment of differentiated 3T3L1 adipocytes with 5µM UK5099 (A – B) or siRNA against <t>MPC1</t> or scramble control (C) . (D - E) Total triglyceride accumulation in adipocytes treated with 5µM UK5099 either throughout (D) , or at various time points during (E) , differentiation. (F) Incorporation of [U- 14 C] acetate into total lipids in differentiated 3T3L1 adipocytes treated with or without 5µM UK5099. Data are mean ± SE for at least three experimental replicates (different cell passages). *P<0.05 vs control, ^P<0.05 vs 10% FBS condition in (A) by paired t-test ( B - D and F ), one-way ANOVA ( E ) or 2-way ANOVA ( A ).
    Antibodies Against Mpc1 And Mpc3, supplied by Agrisera, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against mpc1 and mpc3/product/Agrisera
    Average 90 stars, based on 1 article reviews
    antibodies against mpc1 and mpc3 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Novus Biologicals rabbit polyclonal antibodies against smct1 and mpc1
    MCT family-member and macropinocytosis activities critically regulate bladder cancer cell susceptibility to 3-BrPA - the dispensable role of MPC components. ( a ) Representative (three independent experiments) Western blotting profiles of whole-cell protein extracts obtained from RT4 and T24 cells, seeded at ~60 % confluency and treated with the indicated doses of 3-BrPA for 24 h. The proteins examined were MCT1, MCT4, SMCT1, <t>MPC1</t> and MPC2, while Actin was used as molecule of reference. ( b ) Representative (three independent experiments) immunofluorescence images of MCT1 expression and localization in RT4 and T24 cells, seeded at ~60 % confluency and exposed to the indicated doses of 3-BrPA for 4 h (also, see Fig. ). Scale bars: 3 μm. ( c - e ) MTT cytotoxicity assays of T24 cells, grown at low (and ~60 %; data not shown) confluency and treated with the indicated doses of 3-BrPA for 24 h, in the absence or presence (pre-incubation for the denoted time) of 1 or 10 μM UK-5099 ( c ), 0.1 or 1 μM AR-C155858 ( d ) and 10 or 50 μM EIPA ( e ) (both low and ~60 % confluency allowed the striking survival of 3-BrPA-treated T24 cells grown in the presence of either AR-C155858 or EIPA, but not UK-5099, inhibitor). Each inhibitor remained in the growth medium with half of its initial respective concentration(s) for 24 h more, post-pre-incubation. Survival rates of each cocktail (3-BrPA plus inhibitor) were normalized according to the respective values of inhibitor only. Stock solutions of all three inhibitors (UK-5099, AR-C155858 and EIPA) ( c - e ) were prepared in DMSO. Pre-incubation (for 1.5 h) of T24 with 100 μM EIPA proved significantly detrimental for the cells (data not shown). ( c - e ) Results are reported as mean ± standard deviation of triplicates of three independent experiments. * P < 0.001
    Rabbit Polyclonal Antibodies Against Smct1 And Mpc1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibodies against smct1 and mpc1/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal antibodies against smct1 and mpc1 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A - C) Incorporation of [2- 14 C] pyruvate into total lipids ( A ), or the fatty acyl or glycerol-glyceride fraction of lipids ( B – C ) following treatment of differentiated 3T3L1 adipocytes with 5µM UK5099 (A – B) or siRNA against MPC1 or scramble control (C) . (D - E) Total triglyceride accumulation in adipocytes treated with 5µM UK5099 either throughout (D) , or at various time points during (E) , differentiation. (F) Incorporation of [U- 14 C] acetate into total lipids in differentiated 3T3L1 adipocytes treated with or without 5µM UK5099. Data are mean ± SE for at least three experimental replicates (different cell passages). *P<0.05 vs control, ^P<0.05 vs 10% FBS condition in (A) by paired t-test ( B - D and F ), one-way ANOVA ( E ) or 2-way ANOVA ( A ).

    Journal: bioRxiv

    Article Title: Sex-dependent adipose glucose partitioning by the mitochondrial pyruvate carrier

    doi: 10.1101/2024.05.11.593540

    Figure Lengend Snippet: (A - C) Incorporation of [2- 14 C] pyruvate into total lipids ( A ), or the fatty acyl or glycerol-glyceride fraction of lipids ( B – C ) following treatment of differentiated 3T3L1 adipocytes with 5µM UK5099 (A – B) or siRNA against MPC1 or scramble control (C) . (D - E) Total triglyceride accumulation in adipocytes treated with 5µM UK5099 either throughout (D) , or at various time points during (E) , differentiation. (F) Incorporation of [U- 14 C] acetate into total lipids in differentiated 3T3L1 adipocytes treated with or without 5µM UK5099. Data are mean ± SE for at least three experimental replicates (different cell passages). *P<0.05 vs control, ^P<0.05 vs 10% FBS condition in (A) by paired t-test ( B - D and F ), one-way ANOVA ( E ) or 2-way ANOVA ( A ).

    Article Snippet: Immunoblot analysis was carried out on cell or adipose lysates using mouse or human primary antibodies against MPC1 (Sigma #HPA045119), MPC2 (Cell Signaling Technologies #46141), GAPDH (Sigma #G8795) and β-Tubulin (Abcam #179513) and developed by chemiluminescence (ECL).

    Techniques:

    (A - B) Normalized, quantified protein expression and representative western blot of mitochondrial pyruvate carrier proteins in subcutaneous adipose tissue from wild type vs genetically obese (ob/ob) mice ( A ) and from human subjects with normal glucose tolerance vs impaired fasting glucose plus impaired glucose tolerance ( B ). ( C - H ) Pearson correlations between the protein expression of MPC1 ( A , D , E ) or MPC2 ( F , G , H ) in subcutaneous adipose tissue and indices of glucose tolerance ( C and F ), insulin sensitivity ( D and G ) and adipose insulin resistance ( E and H ) in human subjects. Data are n=5 ( A ) or n=7 ( B – H ) in each group. *P<0.05, ***P<0.001 vs control group ( A and B ).

    Journal: bioRxiv

    Article Title: Sex-dependent adipose glucose partitioning by the mitochondrial pyruvate carrier

    doi: 10.1101/2024.05.11.593540

    Figure Lengend Snippet: (A - B) Normalized, quantified protein expression and representative western blot of mitochondrial pyruvate carrier proteins in subcutaneous adipose tissue from wild type vs genetically obese (ob/ob) mice ( A ) and from human subjects with normal glucose tolerance vs impaired fasting glucose plus impaired glucose tolerance ( B ). ( C - H ) Pearson correlations between the protein expression of MPC1 ( A , D , E ) or MPC2 ( F , G , H ) in subcutaneous adipose tissue and indices of glucose tolerance ( C and F ), insulin sensitivity ( D and G ) and adipose insulin resistance ( E and H ) in human subjects. Data are n=5 ( A ) or n=7 ( B – H ) in each group. *P<0.05, ***P<0.001 vs control group ( A and B ).

    Article Snippet: Immunoblot analysis was carried out on cell or adipose lysates using mouse or human primary antibodies against MPC1 (Sigma #HPA045119), MPC2 (Cell Signaling Technologies #46141), GAPDH (Sigma #G8795) and β-Tubulin (Abcam #179513) and developed by chemiluminescence (ECL).

    Techniques: Expressing, Western Blot

    (A) MPC1 floxed allele and Adipoq-Cre recombination was visualized by semiquantitative RT-PCR and MPC1 protein knockdown efficacy was verified by western blot of adipose lysates. ( B - C ) Ex vivo incorporation of [2- 14 C] pyruvate into the fatty acyl (lipogenesis B ) or glycerol (glyceroneogenesis C ) moieties of total lipids in epididymal adipose explants from male and female MPC AD-/- mice or LoxP +/+ controls. ( D – E ) Rates of glycerol release ( D ) and non-esterified fatty acid re-esterification ( E ) from epididymal adipose explants from male MPC AD-/- mice or LoxP +/+ controls under basal (unstimulated) conditions or during treatment with insulin or forskolin plus triacsin C. *P<0.05, **P<0.01 for MPC AD-/- vs LoxP +/+ ; ^^P<0.01 for female vs male. Data are mean ± SE for at least five mice per group.

    Journal: bioRxiv

    Article Title: Sex-dependent adipose glucose partitioning by the mitochondrial pyruvate carrier

    doi: 10.1101/2024.05.11.593540

    Figure Lengend Snippet: (A) MPC1 floxed allele and Adipoq-Cre recombination was visualized by semiquantitative RT-PCR and MPC1 protein knockdown efficacy was verified by western blot of adipose lysates. ( B - C ) Ex vivo incorporation of [2- 14 C] pyruvate into the fatty acyl (lipogenesis B ) or glycerol (glyceroneogenesis C ) moieties of total lipids in epididymal adipose explants from male and female MPC AD-/- mice or LoxP +/+ controls. ( D – E ) Rates of glycerol release ( D ) and non-esterified fatty acid re-esterification ( E ) from epididymal adipose explants from male MPC AD-/- mice or LoxP +/+ controls under basal (unstimulated) conditions or during treatment with insulin or forskolin plus triacsin C. *P<0.05, **P<0.01 for MPC AD-/- vs LoxP +/+ ; ^^P<0.01 for female vs male. Data are mean ± SE for at least five mice per group.

    Article Snippet: Immunoblot analysis was carried out on cell or adipose lysates using mouse or human primary antibodies against MPC1 (Sigma #HPA045119), MPC2 (Cell Signaling Technologies #46141), GAPDH (Sigma #G8795) and β-Tubulin (Abcam #179513) and developed by chemiluminescence (ECL).

    Techniques: Reverse Transcription Polymerase Chain Reaction, Western Blot, Ex Vivo

    MCT family-member and macropinocytosis activities critically regulate bladder cancer cell susceptibility to 3-BrPA - the dispensable role of MPC components. ( a ) Representative (three independent experiments) Western blotting profiles of whole-cell protein extracts obtained from RT4 and T24 cells, seeded at ~60 % confluency and treated with the indicated doses of 3-BrPA for 24 h. The proteins examined were MCT1, MCT4, SMCT1, MPC1 and MPC2, while Actin was used as molecule of reference. ( b ) Representative (three independent experiments) immunofluorescence images of MCT1 expression and localization in RT4 and T24 cells, seeded at ~60 % confluency and exposed to the indicated doses of 3-BrPA for 4 h (also, see Fig. ). Scale bars: 3 μm. ( c - e ) MTT cytotoxicity assays of T24 cells, grown at low (and ~60 %; data not shown) confluency and treated with the indicated doses of 3-BrPA for 24 h, in the absence or presence (pre-incubation for the denoted time) of 1 or 10 μM UK-5099 ( c ), 0.1 or 1 μM AR-C155858 ( d ) and 10 or 50 μM EIPA ( e ) (both low and ~60 % confluency allowed the striking survival of 3-BrPA-treated T24 cells grown in the presence of either AR-C155858 or EIPA, but not UK-5099, inhibitor). Each inhibitor remained in the growth medium with half of its initial respective concentration(s) for 24 h more, post-pre-incubation. Survival rates of each cocktail (3-BrPA plus inhibitor) were normalized according to the respective values of inhibitor only. Stock solutions of all three inhibitors (UK-5099, AR-C155858 and EIPA) ( c - e ) were prepared in DMSO. Pre-incubation (for 1.5 h) of T24 with 100 μM EIPA proved significantly detrimental for the cells (data not shown). ( c - e ) Results are reported as mean ± standard deviation of triplicates of three independent experiments. * P < 0.001

    Journal: Molecular Cancer

    Article Title: 3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants

    doi: 10.1186/s12943-015-0399-9

    Figure Lengend Snippet: MCT family-member and macropinocytosis activities critically regulate bladder cancer cell susceptibility to 3-BrPA - the dispensable role of MPC components. ( a ) Representative (three independent experiments) Western blotting profiles of whole-cell protein extracts obtained from RT4 and T24 cells, seeded at ~60 % confluency and treated with the indicated doses of 3-BrPA for 24 h. The proteins examined were MCT1, MCT4, SMCT1, MPC1 and MPC2, while Actin was used as molecule of reference. ( b ) Representative (three independent experiments) immunofluorescence images of MCT1 expression and localization in RT4 and T24 cells, seeded at ~60 % confluency and exposed to the indicated doses of 3-BrPA for 4 h (also, see Fig. ). Scale bars: 3 μm. ( c - e ) MTT cytotoxicity assays of T24 cells, grown at low (and ~60 %; data not shown) confluency and treated with the indicated doses of 3-BrPA for 24 h, in the absence or presence (pre-incubation for the denoted time) of 1 or 10 μM UK-5099 ( c ), 0.1 or 1 μM AR-C155858 ( d ) and 10 or 50 μM EIPA ( e ) (both low and ~60 % confluency allowed the striking survival of 3-BrPA-treated T24 cells grown in the presence of either AR-C155858 or EIPA, but not UK-5099, inhibitor). Each inhibitor remained in the growth medium with half of its initial respective concentration(s) for 24 h more, post-pre-incubation. Survival rates of each cocktail (3-BrPA plus inhibitor) were normalized according to the respective values of inhibitor only. Stock solutions of all three inhibitors (UK-5099, AR-C155858 and EIPA) ( c - e ) were prepared in DMSO. Pre-incubation (for 1.5 h) of T24 with 100 μM EIPA proved significantly detrimental for the cells (data not shown). ( c - e ) Results are reported as mean ± standard deviation of triplicates of three independent experiments. * P < 0.001

    Article Snippet: Rabbit polyclonal antibodies against SMCT1 and MPC1 were purchased from Novus Biologicals LLC (Connecticut, USA).

    Techniques: Western Blot, Immunofluorescence, Expressing, Incubation, Concentration Assay, Standard Deviation